Acosta, S. M., Murillo, L., Sandoval, J., Sanchez, P. V. F., Montejano, J., Castillo, V. A. (2026). Safety and objective response of KRAS G12C inhibitors versus docetaxel in previously treated advanced NSCLC: Meta-analysis of randomized trials.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.e20747